Summary
OFTALMED has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €15,000. Equity remains stable across the filed financial years (±1.3% per year). Its solvency ranks better than 10% of 3,009 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
17-04
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
25-07
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
24-07
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
27-07
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
31-12
Financial
Back to profitnet €10,505
Net result €10,505 after one loss-making year.
29-08
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.